KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Petmed Express (PETS) Enterprise Value (2016 - 2025)

Petmed Express' Enterprise Value history spans 16 years, with the latest figure at -$26.9 million for Q4 2025.

  • For Q4 2025, Enterprise Value rose 46.28% year-over-year to -$26.9 million; the TTM value through Dec 2025 reached -$26.9 million, up 46.28%, while the annual FY2025 figure was -$54.7 million, 1.05% up from the prior year.
  • Enterprise Value reached -$26.9 million in Q4 2025 per PETS's latest filing, up from -$36.1 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$26.9 million in Q4 2025 to a low of -$118.7 million in Q1 2021.
  • Average Enterprise Value over 5 years is -$74.6 million, with a median of -$58.4 million recorded in 2023.
  • Peak YoY movement for Enterprise Value: dropped 28.79% in 2021, then surged 51.77% in 2023.
  • A 5-year view of Enterprise Value shows it stood at -$108.9 million in 2021, then grew by 5.95% to -$102.4 million in 2022, then soared by 51.77% to -$49.4 million in 2023, then dropped by 1.42% to -$50.1 million in 2024, then skyrocketed by 46.28% to -$26.9 million in 2025.
  • Per Business Quant, the three most recent readings for PETS's Enterprise Value are -$26.9 million (Q4 2025), -$36.1 million (Q3 2025), and -$41.1 million (Q2 2025).